129 related articles for article (PubMed ID: 34718091)
1. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles.
Qiu J; Li X; Steenkeste K; Barroca-Aubry N; Aymes-Chodur C; Roger P; Casas-Solvas JM; Vargas-Berenguel A; Rihouey C; Picton L; Gref R
Int J Pharm; 2020 May; 581():119281. PubMed ID: 32276089
[TBL] [Abstract][Full Text] [Related]
3. Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic "Stealth" Nanoparticles for Cancer Therapy.
Li X; Salzano G; Qiu J; Menard M; Berg K; Theodossiou T; Ladavière C; Gref R
Front Bioeng Biotechnol; 2020; 8():1027. PubMed ID: 33042960
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-Loaded Metal-Organic Frameworks Nanoparticles with Engineered Cyclodextrin Coatings: Insights on Drug Location by Solid State NMR Spectroscopy.
Li X; Porcino M; Qiu J; Constantin D; Martineau-Corcos C; Gref R
Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33917756
[TBL] [Abstract][Full Text] [Related]
5. A non-covalent "click chemistry" strategy to efficiently coat highly porous MOF nanoparticles with a stable polymeric shell.
Aykaç A; Noiray M; Malanga M; Agostoni V; Casas-Solvas JM; Fenyvesi É; Gref R; Vargas-Berenguel A
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1606-1616. PubMed ID: 28137620
[TBL] [Abstract][Full Text] [Related]
6. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
[TBL] [Abstract][Full Text] [Related]
7. Comb-like dextran copolymers: A versatile strategy to coat highly porous MOF nanoparticles with a PEG shell.
Cutrone G; Qiu J; Menendez-Miranda M; Casas-Solvas JM; Aykaç A; Li X; Foulkes D; Moreira-Alvarez B; Encinar JR; Ladavière C; Desmaële D; Vargas-Berenguel A; Gref R
Carbohydr Polym; 2019 Nov; 223():115085. PubMed ID: 31426973
[TBL] [Abstract][Full Text] [Related]
8. Highly Porous Hybrid Metal-Organic Nanoparticles Loaded with Gemcitabine Monophosphate: a Multimodal Approach to Improve Chemo- and Radiotherapy.
Li X; Porcel E; Menendez-Miranda M; Qiu J; Yang X; Serre C; Pastor A; Desmaële D; Lacombe S; Gref R
ChemMedChem; 2020 Feb; 15(3):274-283. PubMed ID: 31765517
[TBL] [Abstract][Full Text] [Related]
9. Design of Engineered Cyclodextrin Derivatives for Spontaneous Coating of Highly Porous Metal-Organic Framework Nanoparticles in Aqueous Media.
Cutrone G; Li X; Casas-Solvas JM; Menendez-Miranda M; Qiu J; Benkovics G; Constantin D; Malanga M; Moreira-Alvarez B; Costa-Fernandez JM; García-Fuentes L; Gref R; Vargas-Berenguel A
Nanomaterials (Basel); 2019 Aug; 9(8):. PubMed ID: 31374940
[TBL] [Abstract][Full Text] [Related]
10. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
11. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
[TBL] [Abstract][Full Text] [Related]
12. Highly Efficient Encapsulation of Doxorubicin Hydrochloride in Metal-Organic Frameworks for Synergistic Chemotherapy and Chemodynamic Therapy.
Yao L; Tang Y; Cao W; Cui Y; Qian G
ACS Biomater Sci Eng; 2021 Oct; 7(10):4999-5006. PubMed ID: 34550683
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Metal-Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility.
Chen X; Zhuang Y; Rampal N; Hewitt R; Divitini G; O'Keefe CA; Liu X; Whitaker DJ; Wills JW; Jugdaohsingh R; Powell JJ; Yu H; Grey CP; Scherman OA; Fairen-Jimenez D
J Am Chem Soc; 2021 Sep; 143(34):13557-13572. PubMed ID: 34357768
[TBL] [Abstract][Full Text] [Related]
15. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
16. When drug nanocarriers miss their target: extracellular diffusion and cell uptake are not enough to be effective.
Pautu V; Zhao H; Mielcarek A; Balasso A; Couvreur P; Serre C; Mura S
Biomater Sci; 2021 Aug; 9(16):5407-5414. PubMed ID: 34318804
[TBL] [Abstract][Full Text] [Related]
17. Efficient "green" encapsulation of a highly hydrophilic anticancer drug in metal-organic framework nanoparticles.
Rodriguez-Ruiz V; Maksimenko A; Anand R; Monti S; Agostoni V; Couvreur P; Lampropoulou M; Yannakopoulou K; Gref R
J Drug Target; 2015; 23(7-8):759-67. PubMed ID: 26453171
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
[TBL] [Abstract][Full Text] [Related]
19. Construction of Hyaluronic Acid-Covered Hierarchically Porous MIL-nanoMOF for Loading and Controlled Release of Doxorubicin.
Yao YR; Jin YJ; Jia X; Yang Y
Chemistry; 2021 Feb; 27(9):2987-2992. PubMed ID: 33169462
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
